This study is in progress, not accepting new patients
A Study of Baricitinib (LY3009104) in Participants With Severe or Very Severe Alopecia Areata
Summary
- Eligibility
- for people ages 18-70 (full criteria)
- Location
- at Irvine, California and other locations
- Dates
- study startedestimated completion
Description
Summary
Official Title
Keywords
Eligibility
Locations
Details
- Status
- in progress, not accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- Eli Lilly and Company
- Links
- A Study of Baricitinib (LY3009104) in Participants With Severe or Very Severe Alopecia Areata (Hair Loss)
- ID
- NCT03570749
- Phase
- Phase 2/3
- Study Type
- Interventional
- Last Updated